Form 4: Zimmer Biomet Director Christopher Begley Reports Phantom Stock Unit Acquisition

Director Christopher B. Begley reports the acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.

Summary

• Christopher B. Begley, a director of Zimmer Biomet Holdings, Inc., reported the acquisition of 533.286 phantom stock units on March 31, 2025.
• These units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• The units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.
• The reporting person directly owns 21,937.582 phantom stock units.
• This amount includes 45.338 phantom stock units accrued on January 31, 2025, under the dividend reinvestment provision of the plan.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and alignment of director interests with the company's performance.

Positives

• The acquisition of phantom stock units aligns the director's interests with the long-term performance of the company.
• The deferred compensation plan allows for tax-deferred accumulation of wealth.

Future Outlook

The phantom stock units will be settled in cash within sixty days after cessation of the reporting person's service as a Director.

Industry Context

This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It reflects the ongoing accrual of benefits under deferred compensation plans.

Comparison to Industry Standards

• Deferred compensation plans are a common component of executive compensation packages in the medical device industry.
• Companies like Stryker and Medtronic also utilize similar deferred compensation plans for their non-employee directors.
• The specific terms and conditions of these plans can vary, but the general purpose is to align director interests with shareholder value.

Stakeholder Impact

• The acquisition of phantom stock units by a director can positively influence shareholder confidence by aligning management's interests with those of the shareholders.

Key Dates

Keywords

Zimmer Biomet, Director, Phantom Stock Units, Deferred Compensation Plan, Beneficial Ownership, Form 4